
The European Commission, the EU national competition authorities, as well as the EFTA Surveillance Authority (‘European Competition Network’ or ‘ECN‘), have published a joint statement on the application of competition law in the context of the Russian invasion of Ukraine.
In its statement, the ECN acknowledges that the current crisis conditions may trigger the need for companies to address severe disruptions caused by the impact of the war and/or of sanctions in the single market.
This may include cooperation to, for example, (i) ensure the purchase, supply, and fair distribution of scarce products and inputs; or (ii) mitigate severe economic consequences including those arising from compliance with sanctions imposed by the EU.
This type of cooperation would likely either not amount to a restriction of competition, or would generate efficiencies that would most likely outweigh any such restriction.
In this context, the ECN stated that it will not actively intervene against strictly necessary and temporary initiatives specifically targeted at avoiding the severe disruptions caused by the impact of the war and/or of sanctions in the single market.
Companies can reach out to the members of the ECN at any time for informal guidance regarding the compatibility of their initiatives with EU/European Economic Area competition law.
At the same time, the ECN will not hesitate to take action against companies taking advantage of the current situation by entering into cartels or abusing their dominant position.
For more information, please see Commission’s website here
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas